ZEALAND PHARMA A/S (22Z.DE) Stock Income Statement
Europe - FRA:22Z - DK0060257814 - Common Stock
60.34 EUR
+60.34 (+Infinity%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.11B | 62.69M | 342.79M | 103.99M | 108.55M | |||
| Cost Of Goods | -5.40M | 7.87M | 19.17M | 0.00 | 10.97M | |||
| Gross Profit | 9.12B | 54.82M | 323.61M | 103.99M | 97.58M | |||
| Operating Expenses | 1.74B | 1.32B | 884.85M | 879.85M | 879.72M | |||
| Research and Development | 1.27B | 900.27M | 666.33M | 590.19M | 561.63M | |||
| Selling, General, and Administrative Expenses | 461.11M | 397.77M | 190.22M | 263.82M | 293.73M | |||
| Operating Income | 7.38B | -1.27B | -561.24M | -775.86M | -782.14M | |||
| Interest Income/Expense | 37.37M | 195.62M | 18.57M | -14.87M | 18.83M | |||
| Other Income/Expense | -5.14M | -6.85M | -19.61M | 2.57M | 6.60M | |||
| Non Recurring Items | N/A | -3.14M | -146.59M | -183.88M | -2.17M | |||
| Income Before Taxes | 7.21B | -1.08B | -708.87M | -972.04M | -758.89M | |||
| Income Tax | 534.00M | -4.62M | -5.13M | -6.43M | -3.95M | |||
| Net Income | 6.68B | -1.08B | -703.74M | -1.20B | -1.02B | |||
| EBITDA | 7.40B | -1.24B | -536.15M | -657.90M | -741.89M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 92.98 | -16.24 | -12.44 | -26.02 | -23.75 | |||
| Non GAAP EPS | 94.97 | -16.27 | -12.44 | -26.02 | -23.75 | |||
| Statistics | ||||||||
| Gross Profit Margin | 100.06% | 87.44% | 94.41% | 100.00% | 89.89% | |||
| Profit Margin | 73.34% | -1720.87% | -205.30% | -1156.05% | -937.99% | |||
| Operating Profit Margin | 81.00% | -2024.33% | -163.73% | -746.12% | -720.56% | |||
All data in DKK